Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
InfuSystems HoldingsINFU +0.49%85 Equity-to-Asset is 0.61 as of Jun. 2026, which is 27% above its 10-year median of 0.48. GuruFocus rates INFU with a GF Score™ of 85/100 and a GF Value™ of $9.27 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 851 Medical Devices & Instruments companies, InfuSystems Holdings ranks worse than 52.88% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. InfuSystems Holdings's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $59.1 Mil. InfuSystems Holdings's Total Assets for the quarter that ended in Jun. 2026 was $97.7 Mil.
Therefore, InfuSystems Holdings's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.61.
The historical rank and industry rank for InfuSystems Holdings's Equity-to-Asset or its related term are showing as below:
INFU'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.27 Med: 0.48 Max: 0.61
Current: 0.61
During the past 13 years, the highest Equity to Asset Ratio of InfuSystems Holdings was 0.61. The lowest was 0.27. And the median was 0.48.
INFU's Equity-to-Asset is ranked worse than 52.88% of 851
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs INFU: 0.61
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
InfuSystems Holdings Equity-to-Asset Related Terms
InfuSystems Holdings Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for InfuSystems Holdings's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
INFU vs ELMD, LAB, STIM: Equity-to-Asset Comparison
For the Medical Devices subindustry, InfuSystems Holdings's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InfuSystems Holdings Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, InfuSystems Holdings's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where InfuSystems Holdings's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
InfuSystems Holdings's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InfuSystems Holdings (INFU) has a Equity-to-Asset of 0.61 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on InfuSystems Holdings and its competitors. This is 27% above median its historical median of 0.48. Over the past decade, InfuSystems Holdings' Equity-to-Asset has ranged from 0.27 to 0.61. According to the industry distribution chart, InfuSystems Holdings ranks #450 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 52.9%.
Is InfuSystems Holdings' Equity-to-Asset too high?
InfuSystems Holdings' current Equity-to-Asset of 0.61 is 27% above median its 10-year median of 0.48. Over the past 10 years, this metric has ranged from a low of 0.27 to a high of 0.61. The Medical Devices & Instruments industry median Equity-to-Asset is 0.64. InfuSystems Holdings' value of 0.61 is 4.7% below this industry median. Based on the distribution chart, InfuSystems Holdings ranks #450 out of 851 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, InfuSystems Holdings has a GF Score™ of 85/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does InfuSystems Holdings' Equity-to-Asset compare to ELMD and LAB?
According to the Medical Devices & Instruments industry distribution chart, InfuSystems Holdings ranks #450 out of 851 companies for Equity-to-Asset. This places InfuSystems Holdings in the lower half of its industry. The industry median Equity-to-Asset is 0.64. InfuSystems Holdings' value of 0.61 is 4.7% below this benchmark. Historically, InfuSystems Holdings' own Equity-to-Asset has ranged from 0.27 to 0.61 over the past decade. While the company's 10-year median is 0.48 vs. the industry median of 0.64, InfuSystems Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. InfuSystems Holdings's current Equity-to-Asset of 0.61 is 4.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on InfuSystems Holdings and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InfuSystems Holdings's current Equity-to-Asset is 0.61, which is 27% above median its own 10-year median of 0.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InfuSystems Holdings stock overvalued right now?
Based on GuruFocus' analysis, InfuSystems Holdings (INFU) is currently considered Significantly Overvalued. The stock's GF Value™ is $9.27, compared to a current price of $12.24 — trading 32% above its estimated fair value. The current Equity-to-Asset is 0.61, which is 27% above median its 10-year median of 0.48 and 4.7% below the Medical Devices & Instruments industry median of 0.64. InfuSystems Holdings' overall GF Score™ is 85/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For InfuSystems Holdings (INFU), the current Equity-to-Asset is 0.61 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is InfuSystems Holdings (INFU) Overvalued in 2026?
Based on GuruFocus' analysis, InfuSystems Holdings stock appears to be overvalued.
The current stock price of $12.24 is trading 32% above its estimated GF Value™ of $9.27.
GuruFocus considers InfuSystems Holdings to be Significantly Overvalued.
Key valuation signals for INFU:
Equity-to-Asset: 0.61 (27% above median its 10-year median of 0.48)
GF Value™: $9.27 vs. price of $12.24 (32% above fair value)
Industry Position: 4.7% below the Medical Devices & Instruments median (#450 of 851)
No single metric tells the full story. See the INFU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.
85GF Score
Get the complete analysis for INFU
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
INFU has been successfully added to your 
